Jump to Content
User Account
Sign In
to save searches and organize your favorite content.
Not registered?
Sign up
My Content
(0)
Recently viewed
(0)
Save Entry
Searches
(0)
Recently viewed
(0)
Save Search
More
Subscriptions
Join E-mail List
Help
JNCCN
Menu
Home
Content
Current Issue
Past Issues
Featured Online Content
Supplements
NCCN Meeting Highlights
JNCCN In the News
NCCN News
Highlights of the NCCN Oncology Research Program
Video Roundtables
CE
JNCCN 360
Author Center
Call for Papers
Submit a Manuscript
Information for Authors
Reprints/Permissions
About
JNCCN
Editorial Board
Editorial Calendar
NCCN
Conexiant (FKA Harborside)
Reducing Disparities in Cancer Care
Search
Close
Advanced Search
Help
Volume 20 (2022): Issue 9 (Sep 2022)
in
Journal of the National Comprehensive Cancer Network
Online ISSN:
1540-1413
Print ISSN:
1540-1405
Get eTOC Alerts
Get Ahead of Print Alerts
NCCN Clinical Practice Guidelines in Oncology
Myeloproliferative Neoplasms, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
NCCN Guidelines® Insights
NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022
NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022
Oncology Watch
Together Again!
The Last Word
No Money, Mo’ Problems: Financial Toxicity in the Realm of Cancer Screening
Molecular Insights in Patient Care
Response to Selpercatinib in a Patient With Recurrent Glioblastoma and
RET
Amplification
Original Research
Financial Toxicity and Its Association With Prostate and Colon Cancer Screening
Fecal Immunochemical Testing in Patients With Low-Risk Symptoms of Colorectal Cancer: A Diagnostic Accuracy Study
Healthcare Cost Trajectories in the Last 2 Years of Life Among Patients With a Solid Metastatic Cancer: A Prospective Cohort Study
Prevalence of Breast Cancer Survivors Among Canadian Women
Intravenous Patient-Controlled Analgesia Versus Oral Opioid to Maintain Analgesia for Severe Cancer Pain: A Randomized Phase II Trial
FDG-PET Predicts Neoadjuvant Therapy Response and Survival in Borderline Resectable/Locally Advanced Pancreatic Adenocarcinoma
Review
Interferons as the First Choice of Cytoreduction in Essential Thrombocythemia and Polycythemia Vera
Departments
Highlights of the NCCN Oncology Research Program
NCCN News
Save
Email this content
Share Link
Copy this link, or click below to email it to a friend
Email this content
or copy the link directly:
https://jnccn.org/view/journals/jnccn/20/9/jnccn.20.issue-9.xml
The link was not copied. Your current browser may not support copying via this button.
Link copied successfully
Copy link
Collapse
Expand
Search
Issue
Journal
[18.97.14.86]
18.97.14.86
Sign in to annotate
Close
Edit
Character limit
500
/500
Delete
Cancel
Save
@!
Character limit
500
/500
Cancel
Save
View Expanded
View Table
View Full Size